Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Milestones in the Viral Gastroenteritis Market’s Growth Trajectory From 2025 To 2034?

In recent times, the market size for viral gastroenteritis has been progressively expanding. The market is projected to increase from a $6.75 billion value in 2024 to a $7.06 billion value in 2025, exhibiting a compound annual growth rate (CAGR) of 4.7%. The growth observed in the historic period can be credited to factors like the widespread occurrence of viral infections, global sanitation standards, progress in diagnostic techniques, international travel and tourism, and environmental and climatic conditions.

Anticipated robust expansion is foreseen for the viral gastroenteritis market in the imminent years. The market is projected to swell to a considerable$8.69 billion by 2029, experiencing a compound annual growth rate (CAGR) of 5.3%. The predicted growth during the forecast phase owes much to factors such as global healthcare readiness, the influence of climate change, the adoption of a unified health approach, the presence of epidemiological surveillance systems, educational initiatives and heightened public consciousness. Key patterns expected within the forecast period comprise advancements in vaccine formulation, sophisticated diagnostic techniques, the application of telemedicine in disease identification, cooperative research endeavors, implementation of tailored medical strategies, and the integration of digital health solutions.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12127&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theViral Gastroenteritis Market?

The anticipated rise in cases of gastrointestinal issues is predicted to boost the viral gastroenteritis market’s expansion. Gastrointestinal (GI) diseases frequently affect areas of the gastrointestinal tract. Treatments for virus-induced gastroenteritis provide tailored and effective medication for patients struggling with the condition. For illustration, the Impact of IBD Report 2023 unveiled by the IBD Clinical and Research Centre, a Canadian institute committed to enhancing the lives of individuals diagnosed with Crohn’s disease and ulcerative colitis, noted a prevalence rate of 825 per 100,000 in 2023, indicating that over 320,000 Canadians are affected by inflammatory bowel disease (IBD). The report further projects a 2.44% yearly rise in the prevalence rate, estimating that 1.1% of Canada’s population, or 470,000 citizens, will be living with IBD by 2035. Thus, the escalating rates of gastrointestinal disorders serve as a viable growth driver for the viral gastroenteritis market.

Which Segments in the Viral Gastroenteritis Offer the Most Growth?

The viral gastroenteritismarket covered in this report is segmented –

1) By Drugs: Antibiotics; Antacids; Laxatives; Antimotility Agents; Others Drugs

2) By Diagnosis: Physical Examination; Rapid Stool Test

3) By Indication: Watery Diarrhea; Abdominal Cramps; Pain; Other Indications

4) By Type Of Virus: Norovirus; Rotavirus; Astrovirus; Enteric Adenovirus

5) By End User: Hospitals; Clinics; Pharmaceutical Companies; Diagnostic Centers; Ambulatory Care Centers; Others End Users

Subsegments:

1) By Antibiotics: Broad-Spectrum Antibiotics; Narrow-Spectrum Antibiotics; Penicillins; Macrolides; Cephalosporins

2) By Antacids: Proton Pump Inhibitors (PPIs); Histamine-2 Receptor Antagonists (H2 Blockers); Magnesium-Based Antacids; Calcium-Based Antacids; Sodium Bicarbonate

3) By Laxatives: Bulk-Forming Laxatives; Osmotic Laxatives; Stimulant Laxatives; Stool Softeners

4) By Antimotility Agents: Loperamide; Diphenoxylate

5) By Other Drugs: Oral Rehydration Salts (Ors); Zinc Supplements; Antiemetics

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12127&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theViral Gastroenteritis Market?# Market?

North America was the largest region in the viral gastroenteritis market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral gastroenteritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Current Market Growth and Trends in the Viral Gastroenteritis Industry?

The most prominent trend surfacing in the viral gastroenteritis market is product innovation. Top companies in this industry are putting their efforts into the introduction of novel products, aiming to fortify their market presence. For instance, GlaxoSmithKline PLC, a pharmaceutical company based in the UK, secured authorization from the US Food and Drug Administration (FDA) for its liquid formulation of ROTARIX, delivered via an oral-dosing applicator, to combat rotavirus gastroenteritis in infants. This approval was granted in November 2022. The new form of this presentation is more user-friendly for healthcare practitioners by removing the step of vaccine dose reconstitution upon application. The approval is underpinned by data from international clinical trials which demonstrate safety, tolerability against the lyophilized formulation, and immune response equivalence.

View the full report here:

https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report

What Are the Key Elements That Define the Viral Gastroenteritis Market?

Viral gastroenteritis is an intestinal viral infection characterized by swelling, irritation, and inflammation of the inner lining of your gastrointestinal tract. The signs and symptoms include watery diarrhea, nausea or vomiting, stomach cramps, and a fever.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12127

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model